Cargando…

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report

PURPOSE: The aim of this study was to assess the feasibility and efficacy of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) using three-layered planning target volumes (PTV) for malignant gliomas. MATERIALS AND METHODS: We conducted a retrospective analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Jihye, Suh, Chang-Ok, Park, Kwangwoo, Chang, Jong Hee, Lee, Kyu Sung, Kim, Se Hoon, Chang, Jee Suk, Kim, Joo Ho, Suh, Yang-Gun, Kim, Jun Won, Cho, Jaeho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874925/ https://www.ncbi.nlm.nih.gov/pubmed/24339289 http://dx.doi.org/10.3349/ymj.2014.55.1.70

Ejemplares similares

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
por: Lee, Byung Min, et al.
Publicado: (2020)

The role of radiotherapy in the management of POEMS syndrome
por: Suh, Yang-Gun, et al.
Publicado: (2014)

Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
por: Kim, Hyunjung, et al.
Publicado: (2014)

Radiotherapy for Diffuse Intrinsic Pontine Glioma: Insufficient but Indispensable
por: Kim, Hyun Ju, et al.
Publicado: (2023)

Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
por: Im, Jung Ho, et al.
Publicado: (2018)

Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
por: Cho, Jaeho, et al.
Publicado: (2008)

The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
por: Kim, Tae Hyung, et al.
Publicado: (2016)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Hypofractionated intensity-modulated radiotherapy in patients with localized prostate cancer: a preliminary study
por: Kang, Hye Jin, et al.
Publicado: (2016)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
por: Choi, Seo Hee, et al.
Publicado: (2017)

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors
por: Lee, Jeongshim, et al.
Publicado: (2016)

Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma
por: Kim, Hyun Ju, et al.
Publicado: (2018)

Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Lee, Joongyo, et al.
Publicado: (2022)

The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiation
por: Lee, Ha Yoon, et al.
Publicado: (2013)

ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data
por: Kim, Nalee, et al.
Publicado: (2020)

Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
por: Choi, Seo Hee, et al.
Publicado: (2015)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
por: Schmitt, Martin, et al.
Publicado: (2022)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Dosimetric comparison of VitalBeam(®) and Halcyon(TM) 2.0 for hypofractionated VMAT with simultaneous integrated boost treatment of early‐stage left‐sided breast cancer
por: Ju, Eunbin, et al.
Publicado: (2021)

Hypofractionated Radiotherapy With Volumetric Modulated Arc Therapy Decreases Postoperative Complications in Prosthetic Breast Reconstructions: A Clinicopathologic Study
por: Song, Seung Yong, et al.
Publicado: (2020)

Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma
por: Hayashi, Akiko, et al.
Publicado: (2020)

Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
por: Gregucci, Fabiana, et al.
Publicado: (2021)

Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report
por: Choi, Chihwan, et al.
Publicado: (2015)

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
por: Byun, Hwa Kyung, et al.
Publicado: (2019)

Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival
por: Lee, Jeongshim, et al.
Publicado: (2018)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Radiotherapy for initial clinically positive internal mammary nodes in breast cancer
por: Kim, Jina, et al.
Publicado: (2019)

Local ablative radiotherapy for oligometastatic non-small cell lung cancer
por: Suh, Yang-Gun, et al.
Publicado: (2019)

Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
por: Cho, Jae Ho, et al.
Publicado: (2009)

Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma
por: Biau, Julian, et al.
Publicado: (2017)

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality
por: Akgun, Zuleyha, et al.
Publicado: (2023)

Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
por: Hong, Je Beom, et al.
Publicado: (2020)

Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis
por: Dong, Jinling, et al.
Publicado: (2021)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience
por: Kim, Tae Hyung, et al.
Publicado: (2014)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j9056ag3c6dpcdipml7sovng7k